Improvement of Quality of Life after Surgical Treatment of Patients with MRONJ: A Prospective Analysis Using the SF-12 and OHIP-14 Questionnaires.


Journal

International journal of dentistry
ISSN: 1687-8728
Titre abrégé: Int J Dent
Pays: Egypt
ID NLM: 101524183

Informations de publication

Date de publication:
2024
Historique:
received: 22 07 2023
revised: 16 02 2024
accepted: 16 04 2024
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 8 5 2024
Statut: epublish

Résumé

Medication-related osteonecrosis of the jaw (MRONJ) is a rare, serious, and debilitating disease of unknown cause that can be associated with significant health-related quality of life (HRQOL) impairment. Hematological disease is characterized by a nonhealing exposed jawbone in patients with a history of antiresorptive or antiangiogenic agent use without radiation exposure to the head or neck. A total of 27 patients considered in the study had a total of 42 MRONJ lesions, corresponding to a mean of 1.56 necroses per patient. MRONJ lesions were downstaged in 85% of the patients. HRQOL was evaluated with the SF-12 questionnaire. Significant improvements were found in six of the eight categories (General Health ( With completed surgical therapy, improvements in HRQOL and OHRQOL are measurable.

Sections du résumé

Background UNASSIGNED
Medication-related osteonecrosis of the jaw (MRONJ) is a rare, serious, and debilitating disease of unknown cause that can be associated with significant health-related quality of life (HRQOL) impairment. Hematological disease is characterized by a nonhealing exposed jawbone in patients with a history of antiresorptive or antiangiogenic agent use without radiation exposure to the head or neck.
Results UNASSIGNED
A total of 27 patients considered in the study had a total of 42 MRONJ lesions, corresponding to a mean of 1.56 necroses per patient. MRONJ lesions were downstaged in 85% of the patients. HRQOL was evaluated with the SF-12 questionnaire. Significant improvements were found in six of the eight categories (General Health (
Conclusion UNASSIGNED
With completed surgical therapy, improvements in HRQOL and OHRQOL are measurable.

Identifiants

pubmed: 38715871
doi: 10.1155/2024/4435791
pmc: PMC11074825
doi:

Types de publication

Journal Article

Langues

eng

Pagination

4435791

Informations de copyright

Copyright © 2024 Georg Hoene et al.

Déclaration de conflit d'intérêts

The authors have declared that no conflicts of interest exist.

Auteurs

Georg Hoene (G)

Clinic for Oral and Maxillofacial Surgery, University Medical Center Goettingen, Robert Koch-Str. 40, 37075, Goettingen, Germany.

Nikolaus von Hahn (N)

Clinic for Oral and Maxillofacial Surgery, University Medical Center Goettingen, Robert Koch-Str. 40, 37075, Goettingen, Germany.

Denise Sievers (D)

Polyclinic for Orthodontics, University Medical Center Goettingen, Robert Koch-Str. 40, 37075, Goettingen, Germany.

Lukas Schuffelen (L)

Clinic for Oral and Maxillofacial Surgery, University Medical Center Goettingen, Robert Koch-Str. 40, 37075, Goettingen, Germany.

Susanne Wolfer (S)

Clinic for Oral and Maxillofacial Surgery, University Medical Center Goettingen, Robert Koch-Str. 40, 37075, Goettingen, Germany.

Kathi Goldstein (K)

Clinic for Oral and Maxillofacial Surgery, University Medical Center Goettingen, Robert Koch-Str. 40, 37075, Goettingen, Germany.

Boris Schminke (B)

Clinic for Oral and Maxillofacial Surgery, University Medical Center Goettingen, Robert Koch-Str. 40, 37075, Goettingen, Germany.

Phillipp Brockmeyer (P)

Clinic for Oral and Maxillofacial Surgery, University Medical Center Goettingen, Robert Koch-Str. 40, 37075, Goettingen, Germany.

Philipp Kauffmann (P)

Clinic for Oral and Maxillofacial Surgery, University Medical Center Goettingen, Robert Koch-Str. 40, 37075, Goettingen, Germany.

Classifications MeSH